BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14513422)

  • 1. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients.
    Nahimana A; Rabodonirina M; Zanetti G; Meneau I; Francioli P; Bille J; Hauser PM
    J Infect Dis; 2003 Oct; 188(7):1017-23. PubMed ID: 14513422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene.
    Huang L; Beard CB; Creasman J; Levy D; Duchin JS; Lee S; Pieniazek N; Carter JL; del Rio C; Rimland D; Navin TR
    J Infect Dis; 2000 Oct; 182(4):1192-8. PubMed ID: 10979917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
    Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
    J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda.
    Dorsey G; Dokomajilar C; Kiggundu M; Staedke SG; Kamya MR; Rosenthal PJ
    Am J Trop Med Hyg; 2004 Dec; 71(6):758-63. PubMed ID: 15642967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae.
    Meneau I; Sanglard D; Bille J; Hauser PM
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2610-6. PubMed ID: 15215117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of dihydropteroate (DHPS) gene mutant in Pneumocystis carinii in respiratory samples of HIV+ patients from 1992 to 1997.
    Visconti E; Ortona E; Margutti P; Marinaci S; Zolfo M; Mencarini P; Celentano LP; Siracusano A; Tamburrini E
    J Eukaryot Microbiol; 1999; 46(5):132S. PubMed ID: 10519286
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
    Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
    Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations.
    Hauser PM; Nahimana A; Taffe P; Weber R; Francioli P; Bille J; Rabodonirina M
    Clin Infect Dis; 2010 Aug; 51(4):e28-33. PubMed ID: 20604718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
    Biswas S
    J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality.
    Singh Y; Mirdha BR; Guleria R; Kabra SK; Mohan A; Chaudhry R; Kumar L; Dwivedi SN; Agarwal SK
    J Glob Antimicrob Resist; 2019 Jun; 17():236-239. PubMed ID: 30658203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
    Alifrangis M; Enosse S; Khalil IF; Tarimo DS; Lemnge MM; Thompson R; Bygbjerg IC; Rønn AM
    Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of mutations in the human-derived Pneumocystis carinii dihydropteroate synthase gene associated with sulfa resistance.
    Ma L; Kovacs JA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):776-80. PubMed ID: 11181359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain.
    Friaza V; Morilla R; Respaldiza N; de la Horra C; Calderón EJ
    Postgrad Med; 2010 Nov; 122(6):24-8. PubMed ID: 21084778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of multiple loci suggests that mutations in the Pneumocystis carinii f. sp. hominis dihydropteroate synthase gene arose independently in multiple strains.
    Ma L; Kovacs JA
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3213-5. PubMed ID: 11600382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropteroate synthase gene mutations in Pneumocystis jiroveci strains isolated from immunocompromised patients.
    Jarboui MA; Sellami A; Sellami H; Cheikhrouhou F; Makni F; Ayadi A
    Pathol Biol (Paris); 2011 Aug; 59(4):222-5. PubMed ID: 20346596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R; Basco LK
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
    Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis.
    Nahimana A; Rabodonirina M; Bille J; Francioli P; Hauser PM
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4301-5. PubMed ID: 15504856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.